Consultation on regulatory amendments regarding test kits containing controlled substances
Current status: Open
Opened on March 30, 2018 and will close on May 29, 2018.
You are invited to provide comments on a proposal to align, streamline and modernize the registration of test kits under various regulations under the Controlled Drugs and Substances Act (CDSA).
Join in: How to participate
Read our Notice to Interested Parties which provides more details on the proposal.
Send us an email
Send an email to email@example.com with your input or comments.
Participate by mail
Send a letter with your input or comments to the address in the contact information section.
Goals of the consultation
Test kits are essential in supporting public health and safety of Canadians.
Law enforcement agencies such as the Royal Canadian Mounted Police, Canada Border Services Agency and Health Canada’s Drug Analysis Service laboratories often rely on test kits to analyze seized substances. Forensic laboratories use test kits for the analysis of biological samples for controlled substances.
Health Canada authorizes test kits containing controlled substances through the registration of the product under various regulations under the CDSA.
A review of requirements related to test kits has shown inconsistencies and redundancies. We intend to modernize, streamline and align the requirements regarding test kits in the regulations under the CDSA and so that they are more responsive, clear and consistent across the regulations for manufacturers and importers of test kits.
- Narcotic Control Regulations
- Benzodiazepines and Other Targeted Substances Regulations
- Food and Drug Regulations
- Controlled Drugs and Substances Act
Office of Legislative and Regulatory Affairs
150 Tunney’s Pasture Driveway, Main Stats Building - 2605A
Ottawa ON K1A 0K9
Report a problem or mistake on this page
- Date modified: